The International BAU Drug Design Congress is a highly esteemed event that brings together professionals, researchers, scientists, and experts from the field of drug design and development. It serves as a platform to facilitate knowledge exchange, explore emerging trends, and discuss the latest advancements in drug discovery and development.

The main theme of the 9^th International BAU–Drug Design Congress will be “Integrating Artificial Intelligence Approaches with Multi-scale Molecular Modeling Approaches into Small Molecule and Biologic Therapeutics Design” which will cover a wide range of critically important topics such as:

• From Bench to Clinical Applications
• Analysis of Protein/Protein and Drug/Protein Interactions
• High Throughput Screening Methods
• Pharmacophore Modeling
• Protein Flexibility and Dynamics
• High Performance Computing
• Ligand-based and Structure-based Approaches to DrugDesign
• Computational Methods for Nanotechnology in DrugDesign
• Data Mining in Drug Discovery and Design
• Big Data Analysis in Drug Discovery Field
• Virtual Screening Approaches and Molecular Dynamics Simulations in Drug Design